AKT1 and metabolic dysfunction-associated steatotic liver disease: SJGJ was primarily involved in PPAR, AMPK, and NAFLD pathways, while SJY significantly enriched AMPK, PI3K-Akt, and lipid metabolism pathways (Figure 10E).